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ABSTRACT
COPD- derived fibroblasts have increased cellular 
senescence. Senescent cell accumulation can induce 
tissue dysfunction by their senescence- associated 
secretory phenotype (SASP). We aimed to determine the 
SASP of senescent fibroblasts and COPD- derived lung 
fibroblasts, including severe, early- onset (SEO)- COPD. 
SASP protein secretion was measured after paraquat- 
induced senescence in lung fibroblasts using Olink 
Proteomics and compared between (SEO- )COPD- derived 
and control- derived fibroblasts. We identified 124 SASP 
proteins of senescent lung fibroblasts, of which 42 were 
secreted at higher levels by COPD- derived fibroblasts 
and 35 by SEO- COPD- derived fibroblasts compared 
with controls. Interestingly, the (SEO- )COPD- associated 
SASP included proteins involved in chronic inflammation, 
which may contribute to (SEO- )COPD pathogenesis.
INTRODUCTION
Accelerated lung ageing has been postulated to 
contribute to the pathogenesis of COPD.1 Several 
mechanisms of accelerated ageing have been iden-
tified in COPD,1 2 of which cellular senescence 
is most extensively described to be increased in 
lung tissue and structural cells from patients with 
COPD.3 Cellular senescence is an irreversible cell 
cycle arrest that prevents cell death.4 Senescent 
cells secrete (pro- inflammatory) proteins, called 
the senescence- associated secretory phenotype 
(SASP), to recruit immune cells for their clearance. 
However, on accumulation of senescent cells, high 
levels of SASP proteins can have detrimental effects 
on the surrounding tissue, by inducing chronic 
inflammation and tissue dysfunction.5 The SASP is 
cell type specific and its potential (negative) impact 
on surrounding cells largely depends on the compo-
sition and level of secretion of these SASP proteins. 
Examples of previously described SASP proteins 
include interleukins, chemokines, growth factors 
and proteases.6 7
Recently, we demonstrated higher levels of 
cellular senescence in lung fibroblasts and lung tissue 
from patients with older, mild- moderate COPD 
and patients with severe, early- onset (SEO)- COPD 
compared with their matched controls.8 Patients 
with SEO- COPD develop very severe COPD at a 
relatively early age with relatively low numbers of 
pack- years. Thus, accelerated lung ageing, including 
cellular senescence, may contribute to SEO- COPD. 
The SASP of senescent primary lung fibroblasts and 
COPD- derived fibroblasts is not defined yet and 
thus the potential impact of senescent fibroblasts on 
the surrounding lung tissue is unclear. Therefore, 
we aimed to first identify SASP proteins of senes-
cent primary human lung fibroblasts and second 
to determine which of these SASP proteins are 
secreted at higher levels by COPD- derived fibro-
blasts, including SEO- COPD, compared with their 
matched non- COPD control- derived fibroblasts.
METHODS
Cell culture supernatants from lung fibroblasts 
from 10 patients with SEO- COPD and 11 patients 
with older, mild- moderate COPD and, respec-
tively, 9 and 10 matched non- COPD controls were 
used (table 1), which were collected as previously 
described8 (a detailed description of the methods 
can be found in the online supplemental). Briefly, 
cellular senescence was induced in fibroblasts from 
all subject groups by paraquat (PQ) treatment 
(250 µM for 24 hours), which by occupational expo-
sure is a risk factor for COPD, and can induce senes-
cence specifically via mitochondrial reactive oxygen 
species production.9 10 Senescence induction was 
confirmed by a 40% increase in SA-β-gal positive 
cells and a sevenfold increase in p21 expression.8 
Cell culture supernatants were collected 4 days after 
senescence induction. The highly sensitive Olink 
Proteomics (Olink Proteomics, Uppsala, Sweden) 
panels Inflammation and Cardiovascular III were 
used to measure the secretion of 184 proteins, 
whereof 165 proteins passed quality control. Since 
cell numbers at the end of culture were significantly 
different between COPD and control and between 
PQ and untreated (online supplemental figure 
S1), levels of secreted proteins were corrected for 
these cell numbers. Significant differences between 
PQ treated and untreated cells were tested using 
Wilcoxon signed- rank test adjusted for multiple 
testing using Benjamini- Hochberg. Proteins 
were defined as SASP protein when a significant 
(FDR<0.05) ≥threefold increase in secretion was 
observed after PQ treatment. Next, statistical differ-
ences in SASP protein secretion between untreated 
COPD- derived and control- derived fibroblasts 
were tested using Mann- Whitney U test. FDR 
p<0.05 was considered statistically significant. 
Finally, pathway analysis of COPD- associated SASP 
proteins was performed using the STRING data-
base (V.11.0) to provide more insight into the func-
tion of the SASP proteins and their potential role in 
COPD, while it should be noted that the selected 
panels may have caused a bias in the analysis.
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First, the secretion of 124 proteins was significantly increased 
≥threefold after senescence induction by PQ and these proteins 
were thus defined as SASP proteins of senescent primary lung 
fibroblasts (top-50 is shown in figure 1A, see online supple-
mental table S1 for all SASP proteins). We compared our SASP 
composition with the recently published SASP Atlas7 and other 
literature and included the overlap in online supplemental table 
S1. From the 124 found SASP proteins 70 were previously 
described, including GDF-15 and CCL-3 (figure 1B). In addi-
tion, our approach revealed 54 potentially novel SASP proteins, 
including GDNF and TGF-α (figure 1C). We validated the Olink 
Table 1 Subject characteristics of fibroblasts of combined groups and subgroups
Variable Control COPD P value Variable
Control (SEO- 




moderate COPD P value
Number 19 21 Number 9 10 10 11
Age, mean years 
(range)
61 (42–81) 62 (44–81) 0.844 Age, mean years 
(range)
52 (42–59) 50 (44–55) 0.349 70 (65–81) 73 (66–81) 0.176
Male/female, n 9/10 12/9 0.548 Male/female, n 1/8 2/8 0.556 8/2 10/1 0.500
Pack- years 34 (28–40) 30 (15–50) 0.627 Pack- years 32 (28–35) 26 (14–30) 0.673 43 (28–51) 49 (19–53) 0.823
Stop- months, 120 (30–240) 78 (36–96) 0.337 Stop- months 84 (18–168) 78 (63–93) 0.677 186 (81–252) 66 (27–96) 0.421
Non- COPD, n 19 – Non- COPD, n 9 – 10 –
COPD, n – 21 COPD, n – 10 – 11
  GOLD 1 – –   GOLD 1 – – – –
  GOLD 2 – 7   GOLD 2 – – – 7
  GOLD 3 – 4   GOLD 3 – – – 4
  GOLD 4 – 10   GOLD 4 – 10 – –
FEV1 %pred 88.1 (82.5–98.0) 38.8 (17.1–66.7) 0.000 FEV1 %pred 87.0 (83.5–92.0) 16.5 (14.3–22.7) 0.000 90.7 (82.2–104.0) 66.7 (43.4–70.5) 0.000
FVC %pred 90.3 (83.0–107.5) 77.9 (44.2–83.5) 0.005 FVC %pred 92.8 (84.6–101.0) 42.6 (37.9–68.1) 0.000 89.5 (76.7–107.5) 83.5 (79.7–98.8) 0.647
FEV1/FVC 73.6 (71.8–77.7) 41.8 (28.4–50.0) 0.000 FEV1/FVC 75.9 (73.3–79.0) 27.6 (26.0–38.5) 0.000 72.1 (70.3–75.1) 50.0 (41.7–59.0) 0.000
Data are presented as medians with interquartile ranges unless otherwise stated.
Significant differences between groups were tested using Mann–Whitney U tests or unpaired t- tests. P values are stated.
Gold stage based on FEV1 %pred.
%pred, % predicted; SEO, severe, early- onset.
Figure 1 SASP of senescent primary lung fibroblasts. Graph showing top-50 of 124 significant SASP proteins with highest median fold change and 
IL-8, sorted on fold change (A). Significant differences were tested using Wilcoxon signed- rank tests (n=40). Benjamini- Hochberg adjusted FDR<0.05 
was considered statistically significant. Medians with 95% CI are plotted. Examples of two previously described SASP proteins, that is, GDF-15 and 
CCL3 (B) and two not previously described SASP proteins, that is, GDNF and TGF-α (C) with the highest median fold change are plotted in dot plots 
(for more details see online supplemental table S1). Blue=basal and red=paraquat (PQ) treatment (both n=40). Protein levels are depicted as Olink 
NPX values corrected for total cell numbers. IL-8 protein levels were validated using Human DuoSet ELISA (R&D Systems, Abingdon, UK) (D) and 
correlated with Olink IL-8 levels (D, right panel). Spearman Rho and p value are plotted in the graph. FDR, false discovery rate; IL, interleukin; SASP, 
senescence- associated secretory phenotype.
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Proteomics platform by measuring IL-8 using ELISA. A similar 
increase in IL-8 secretion was detected by ELISA after PQ- in-
duced senescence with a significant positive correlation with 
IL-8 levels measured by Olink Proteomics (figure 1D).
Next, the secreted levels of these 124 defined SASP proteins 
were evaluated in untreated cell culture supernatants from 
patients with COPD compared with their matched control- 
derived fibroblasts. We observed higher levels of 42 SASP proteins 
in supernatants from COPD- derived fibroblasts (figure 2A, see 
online supplemental table S2 for a detailed overview). The three 
proteins with the highest median fold change were RANKL, 
FABP4 and IGFBP-1 (figure 2B). Several of the COPD- associated 
SASP proteins were previously found to be higher expressed at 
the transcription level in COPD- derived lung tissue compared 
with controls, including vWF, CHIT1, SPON1, TR- AP, TIMP4, 
PECAM1, CDH5, PSP- D, IL- 15RA.11 Furthermore, several 
COPD- associated SASP proteins were associated with ageing 
in lung tissue at the transcription level, including t- PA, CHIT1, 
SPON1, IL- 10RA and CXCL9.12 On subgroup analyses, 35 of 
the 42 COPD- associated proteins were secreted at higher levels 
by fibroblasts from patients with SEO- COPD compared with 
their matched controls (online supplemental table S2), whereas 
this was not the case for the patients with older, mild- moderate 
COPD compared with their matched controls.
Finally, STRING pathway analysis revealed that responses 
to stimuli, immune responses and cytokine- related pathways 
are associated with the COPD- associated SASP proteins (data 
not shown). COPD- associated SASP proteins include cytokines 
(IL12B, TNFSF14 and RANKL) and chemokines (CCL15, 
CCL23 and CXCL9) that are known to be involved in inflamma-
tory processes. These findings suggest that the SASP proteins that 
are secreted at higher levels by COPD- derived fibroblasts might 
be involved in the chronic inflammatory response in COPD.
CONCLUSION
By using a proteomic- based approach, we provide insight into 
the SASP of primary human lung fibroblasts. Interestingly, 42 
of the 124 identified SASP proteins were secreted at higher 
levels by fibroblasts from patients with COPD compared with 
matched controls. The COPD- associated SASP proteins include 
proteins that have been implicated in chronic inflammation, and 
thus may contribute to disease pathology in COPD. Remarkably, 
35 of these 42 COPD- associated SASP proteins are secreted at 
higher levels by patients with SEO- COPD compared with their 
matched controls, whereas none were significantly different 
between patients with older, mild- moderate COPD compared 
with their matched controls. This lack of significance is likely 
due to higher biological variation in these older subgroups as the 
fold changes are comparable (online supplemental table S2) and 
the interquartile ranges are higher in these groups (online supple-
mental figure S2). These results suggest a role for these SASP 
proteins in COPD. The fact that both cellular senescence and 
SASP protein secretion were higher in COPD- derived lung fibro-
blasts compared with their matched controls suggests that senes-
cence accumulation is involved in the pathogenesis of COPD. It 
Figure 2 Higher levels of SASP protein secretion by COPD- derived fibroblasts. Graph showing all 42 significant SASP proteins with higher protein 
secretion in COPD- derived fibroblasts (n=21) compared with non- COPD controls (n=19), sorted on fold change (A) (for more details see online 
supplemental table S2). Significant differences were tested using Mann- Whitney U tests. Benjamini- Hochberg adjusted FDR<0.05 was considered 
statistically significant. Medians with 95% CI are plotted. The SEO- COPD- associated SASP proteins are indicated with a star in the graph behind the 
protein names. No older, mild- moderate COPD- associated SASP proteins were found. The three COPD- associated SASP proteins with the highest fold 
change in medians are plotted in dot plots (B). Green=SEO- COPD- matched controls (n=9), red=SEO COPD (n=10), blue=older, mild- moderate COPD- 
matched controls (n=10), yellow=older, mild- moderate COPD (n=11). Protein levels are depicted as Olink NPX values corrected for cell numbers. Lines 
represent medians. SASP, senescence- associated secretory phenotype; SEO, severe, early- onset. FDR, false discovery rate.
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should be noted that until now it is unknown whether the higher 
senescence observed in COPD is driven by acute exposures or 
chronic exposures, which may result in a different SASP profile. 
In addition, different senescence- inducing stimuli may result in a 
different SASP profile as well. The identified (COPD- associated) 
SASP proteins of primary lung fibroblasts can be used for further 
studies to understand the role of senescent cell accumulation and 
its potential detrimental impact in SEO- COPD pathogenesis.
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